NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/03/2026
Voltar para busca
Dado oficial do USPTO
LUPIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
82
Atualização mais recente
31/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
24/06/2009
Data de registro
22/12/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/03/2026
Última transação
31/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
2005-00-00
Primeiro uso no comércio
2005-00-00
Código do desenho
3
Tipo de titular
03
Localização do titular
Naples, FL, US
Examinador
AIKENS, RONALD E
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "Lupin" and a flower shaped design.
Titulares e representantes
Titulares
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc.
Representantes
Robert L. Powley Powley & Gibson, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of infectious and parasitic diseases; antibiotics; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine and metabolic systems; pharmaceutical preparations for the treatment of mental and behavioral conditions and disorders; antidepressants; pharmaceutical preparations for the treatment of diseases and disorders of the nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the eye and adnexa; pharmaceutical preparations for the treatment of diseases and disorders of the ear and mastoid process; pharmaceutical preparations for the treatment of diseases and disorders of the circulatory system; antihypertensives; pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system; pharmaceutical preparations for the treatment of diseases and disorders of the digestive system; pharmaceutical preparations for the treatment of diseases and disorders of the skin and subcutaneous tissue; pharmaceutical preparations for the treatment of diseases and disorders of the musculoskeletal system and connective tissue; pharmaceutical preparations for the treatment of diseases and conditions of the genitourinary system; and pharmaceutical preparations for the treatment of diseases and disorders associated with pregnancychildbirth and the peurperiumcontraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's healthsymptoms and conditions associated with menopausepre-menstruation syndrome and other symptoms and conditions associated with menstruation
Publicações
Histórico de despachos e eventos da marca no USPTO.
82 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/03/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/03/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
18/12/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
22/12/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
30/10/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
30/10/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/10/2021
E815
TEAS SECTION 8 & 15 RECEIVED
23/07/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
22/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
22/12/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
19/11/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
18/11/2015
DMCC
DATA MODIFICATION COMPLETED
18/11/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/11/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/11/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/06/2015
GNRT
NON-FINAL ACTION E-MAILED
01/06/2015
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/06/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/05/2015
IUAF
USE AMENDMENT FILED
23/04/2015
EISU
TEAS STATEMENT OF USE RECEIVED
23/04/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/10/2014
EX5G
SOU EXTENSION 5 GRANTED
21/10/2014
EXT5
SOU EXTENSION 5 FILED
16/10/2014
EEXT
SOU TEAS EXTENSION RECEIVED
16/10/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26/04/2014
EX4G
SOU EXTENSION 4 GRANTED
25/04/2014
EXT4
SOU EXTENSION 4 FILED
21/04/2014
EEXT
SOU TEAS EXTENSION RECEIVED
21/04/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/10/2013
EX3G
SOU EXTENSION 3 GRANTED
23/10/2013
EXT3
SOU EXTENSION 3 FILED
16/10/2013
EEXT
SOU TEAS EXTENSION RECEIVED
16/10/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26/04/2013
EX2G
SOU EXTENSION 2 GRANTED
25/04/2013
EXT2
SOU EXTENSION 2 FILED
23/04/2013
EEXT
SOU TEAS EXTENSION RECEIVED
23/04/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
03/11/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/10/2012
EX1G
SOU EXTENSION 1 GRANTED
29/10/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
29/10/2012
EXT1
SOU EXTENSION 1 FILED
24/10/2012
EEXT
SOU TEAS EXTENSION RECEIVED
24/10/2012
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24/04/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2012
PUBO
PUBLISHED FOR OPPOSITION
28/02/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
26/01/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/01/2012
ACEC
AMENDMENT FROM APPLICANT ENTERED
23/01/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/01/2012
PAPER RECEIVED
17/01/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/09/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/09/2011
CNRT
NON-FINAL ACTION MAILED
12/07/2011
CNRT
NON-FINAL ACTION WRITTEN
12/07/2011
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/07/2011
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
13/06/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/06/2011
ALIE
ASSIGNED TO LIE
31/05/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/05/2011
DOCK
ASSIGNED TO EXAMINER
24/05/2011
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/01/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/12/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2010
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
20/12/2010
CNSL
LETTER OF SUSPENSION MAILED
07/07/2010
CNSL
SUSPENSION LETTER WRITTEN
06/07/2010
CNRT
NON-FINAL ACTION MAILED
14/01/2010
CNRT
NON-FINAL ACTION WRITTEN
14/01/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/12/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/12/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/12/2009
CNRT
NON-FINAL ACTION MAILED
24/09/2009
CNRT
NON-FINAL ACTION WRITTEN
23/09/2009
DOCK
ASSIGNED TO EXAMINER
23/09/2009
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
30/06/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/06/2009
NWAP
NEW APPLICATION ENTERED
27/06/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LUPIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.